PPARA and metabolic dysfunction-associated steatohepatitis: Pharmacological activation of PPARα in the methionine–choline-deficient diet (MCDD) NASH model, reduces lipid peroxidation and TG content in the liver, and reverses steatohepatitis and fibrosis [42,43].